Canagliflozin and Metformin Extended-Release Tablets and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Canagliflozin and Metformin Extended-Release Tablets and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canagliflozin / metformin
Brand name: Invokamet, Invokamet XR
Synonyms: Canagliflozin and metformin, Canagliflozin and Metformin
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canagliflozin and Metformin Extended-Release Tablets-Insulin glargine, recombinant Subcutaneous
- Canagliflozin and Metformin Extended-Release Tablets-Insulin glulisine
- Canagliflozin and Metformin Extended-Release Tablets-Insulin Glulisine (Cartridges and Pens)
- Canagliflozin and Metformin Extended-Release Tablets-Insulin Glulisine (Vials)
- Canagliflozin and Metformin Extended-Release Tablets-Insulin glulisine Subcutaneous
- Canagliflozin and Metformin Extended-Release Tablets-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Canagliflozin and Metformin Tablets
- Insulin glargine and lixisenatide Subcutaneous-Canakinumab
- Insulin glargine and lixisenatide Subcutaneous-Canakinumab Subcutaneous
- Insulin glargine and lixisenatide Subcutaneous-Canasa
- Insulin glargine and lixisenatide Subcutaneous-Canasa Pac rectal
- Insulin glargine and lixisenatide Subcutaneous-Canasa rectal